DCOY Decoy Therapeutics Inc.
Fundamentals / CIK 0001615219 / USDDecoy Therapeutics Inc. reported $8.79M in total assets and a net loss of $16.56M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open DCOY in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$16.96M Operating profit
-
Net Income FY 2025-$16.56M GAAP bottom line
-
Diluted EPS FY 2025-$19.59 Split-adjusted
-
Free Cash Flow FY 2025-$5.40M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$8.17M Total debt: --
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $0 | $1.84M | $5.23M | $3.47M | $1.95M | $1.27M | $1.01M |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | -- | $431K | $507K | $663K |
| Gross Profit | -- | -- | -- | -- | -- | -- | -- | $1.52M | $768K | $348K |
| Research & Development | $368K | $770K | $7.17M | $15.84M | $8.55M | $6.91M | $4.02M | $1.29M | $16.99M | $20.38M |
| Total Operating Expenses | $12.61M | $5.73M | $12.89M | $31.84M | $14.65M | $13.02M | $11.73M | $3.64M | $36.00M | $40.90M |
| Operating Income | -$12.61M | -$5.73M | -$12.89M | -$31.84M | -$12.81M | -$7.79M | -$8.27M | -$1.68M | -$34.73M | -$39.89M |
| EBITDA | -$12.61M | -$5.73M | -$12.88M | -$31.83M | -$12.79M | -$7.77M | -$8.14M | -$1.67M | -$34.40M | -$39.61M |
| Interest Income | -- | -- | -- | -- | -- | -- | -- | $152K | $292K | $393K |
| Income Tax Expense | $0 | -- | -- | -- | -- | -- | $0 | -- | -- | -- |
| Net Income | -$12.52M | -$5.58M | -$12.54M | -$31.61M | -$12.77M | -$7.35M | -$6.94M | -$1.67M | -$34.43M | -$39.49M |
| Basic EPS | -$5,361,295.68 | -$2,887,873.75 | -$229,876,003.56 | -$890,189,963.03 | -$461,845,867.92 | -$747,807,428.62 | -$3,170,703,497.35 | -$1,734,913,234.40 | -$2,976,273,565.90 | -$3,634,344,103.09 |
| Diluted EPS | -$5,361,295.68 | -$2,887,873.75 | -$229,876,003.56 | -$890,189,963.03 | -$461,845,867.92 | -$747,807,428.62 | -$3,170,703,497.35 | -$1,734,913,234.40 | -$2,976,273,565.90 | -$3,634,344,103.09 |
| Basic Shares Outstanding | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted Shares Outstanding | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $307K | $228K | -- | -- | $0 | $0 | -- | -- |
| Research & Development | $1.57M | $1.30M | $750K | $114K | $62K | $116K | $76K | $175K |
| Total Operating Expenses | $3.32M | $2.63M | $2.28M | $9.03M | $895K | $966K | $1.72M | $1.49M |
| Operating Income | -$3.01M | -$2.63M | -$2.28M | -$9.03M | -$895K | -$966K | -$1.72M | -$1.49M |
| EBITDA | -$2.99M | -$2.62M | -$2.28M | -$9.03M | -$894K | -$964K | -$1.72M | -$1.49M |
| Net Income | -$2.99M | -$2.37M | -$2.22M | -$8.98M | -$873K | -$958K | -$1.71M | -$1.46M |
| Basic EPS | -$3.53 | -$4.46 | -$746.43 | -- | -$21.76 | -$81.21 | -$42,869.64 | -- |
| Diluted EPS | -$3.53 | -$4.46 | -$746.43 | -- | -$21.76 | -$81.21 | -$42,869.64 | -- |
| Basic Shares Outstanding | 845.4K | 532.0K | 3.0K | -- | 40.1K | 11.8K | 40 | -- |
| Diluted Shares Outstanding | 845.4K | 532.0K | 3.0K | -- | 40.1K | 11.8K | 40 | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $10.71M | $2.43M | $5.90M | $12.11M | $29.21M | $11.12M | $3.74M | $3.23M | $19.19M | $22.42M |
| Short-Term Investments | -- | -- | -- | -- | -- | -- | -- | $0 | $14.13M | $38.66M |
| Cash & Short-Term Investments | $10.71M | $2.43M | $5.90M | $12.11M | $29.21M | $11.12M | $3.74M | $3.23M | $33.32M | $61.07M |
| Accounts Receivable, Net | -- | -- | -- | -- | $1.60M | $3.90M | $0 | $9.9K | $10K | $12K |
| Inventory | -- | -- | -- | -- | -- | -- | -- | $187K | $432K | $454K |
| Other Current Assets | $275K | $44K | $151K | $168K | $173K | $138K | $136K | $22K | -- | -- |
| Total Current Assets | $10.99M | $2.99M | $6.52M | $14.52M | $30.16M | $15.80M | $4.69M | $6.38M | $34.54M | $62.47M |
| Property, Plant & Equipment, Net | $41K | $0 | -- | -- | $7.9K | $23K | $25K | $38K | $331K | $556K |
| Goodwill | -- | -- | -- | $0 | $8.87M | $8.87M | $8.87M | $0 | -- | -- |
| Long-Term Investments | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| Other Non-Current Assets | $31K | $35K | $67K | $131K | $194K | $247K | $309K | $195K | $0 | $65K |
| Total Non-Current Assets | $72K | $35K | $67K | $131K | $10.67M | $9.14M | $9.20M | $233K | $458K | $748K |
| Total Assets | $11.06M | $3.02M | $6.59M | $14.65M | $40.83M | $24.93M | $13.89M | $6.61M | $34.99M | $63.21M |
| Accounts Payable | $941K | $937K | $603K | $2.86M | $1.54M | $1.85M | $1.79M | $380K | $2.00M | $1.19M |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | $0 | $542K | $4.01M | $72K | $88K |
| Other Current Liabilities | $2.3K | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Current Liabilities | $5.17M | $1.51M | -- | -- | -- | -- | -- | $1.11M | $5.85M | $3.89M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| Total Non-Current Liabilities | $0 | $0 | -- | -- | -- | -- | -- | $6.78M | $39K | $8.4K |
| Total Liabilities | $5.17M | $1.51M | $1.30M | $4.27M | $2.11M | $2.77M | $3.31M | $7.88M | $5.89M | $3.90M |
| Common Stock | $53 | $1 | $49 | $225 | $181 | $2.4K | $451 | $203 | $1.8K | $1.7K |
| Retained Earnings | -$94.44M | -$81.92M | -$76.35M | -$63.81M | -$32.20M | -$19.43M | -$12.08M | -$5.14M | -$111.1M | -$76.65M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | -- | -- | -- | $0 | -$1.2K | -$1.6K |
| Total Stockholders' Equity | $5.89M | $1.51M | $5.29M | $10.38M | $38.72M | $22.16M | $10.58M | -$1.27M | -$2.90M | $59.32M |
| Total Equity | $5.89M | $1.51M | $5.29M | $10.38M | $38.72M | $22.16M | $10.58M | -$1.27M | -$2.90M | $59.32M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $8.17M | $8.29M | $7.82M | $10.71M | $4.81M | $795K | $1.80M | $2.43M |
| Cash & Short-Term Investments | $8.17M | $8.29M | $7.82M | $10.71M | $4.81M | $795K | $1.80M | $2.43M |
| Other Current Assets | $209K | $146K | $306K | $275K | $81K | $26K | $62K | $44K |
| Total Current Assets | $8.38M | $8.57M | $8.36M | $10.99M | $6.06M | $1.36M | $2.31M | $2.99M |
| Property, Plant & Equipment, Net | $385K | $399K | $36K | $41K | -- | -- | -- | $0 |
| Other Non-Current Assets | $28K | $29K | $30K | $31K | $32K | $33K | $34K | $35K |
| Total Non-Current Assets | $413K | $428K | $66K | $72K | $32K | $33K | $34K | $35K |
| Total Assets | $8.79M | $9.00M | $8.42M | $11.06M | $6.10M | $1.39M | $2.34M | $3.02M |
| Accounts Payable | $779K | $1.33M | $936K | $941K | $1.10M | $1.48M | $1.47M | $937K |
| Other Current Liabilities | -- | -- | -- | $2.3K | -- | -- | -- | $0 |
| Total Current Liabilities | $4.25M | $4.68M | $4.55M | $5.17M | -- | -- | -- | $1.51M |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | -- | -- | -- | $0 |
| Total Liabilities | $4.25M | $4.68M | $4.55M | $5.17M | $1.85M | $2.22M | $2.28M | $1.51M |
| Common Stock | $238 | $53 | $53 | $53 | $94 | $213 | $208 | $1 |
| Retained Earnings | -$102.0M | -$99.04M | -$96.67M | -$94.44M | -$85.46M | -$84.59M | -$83.63M | -$81.92M |
| Total Stockholders' Equity | $4.55M | $4.32M | $3.88M | $5.89M | -$4.25M | -$830K | $62K | $1.51M |
| Total Equity | $4.55M | $4.32M | $3.88M | $5.89M | -$4.25M | -$830K | $62K | $1.51M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$12.52M | -$5.58M | -$12.54M | -$31.61M | -$12.77M | -$7.35M | -$6.94M | -$1.67M | -$34.43M | -$39.49M |
| Depreciation & Amortization | $7.2K | $4.4K | $10K | $6.7K | $19K | $18K | $127K | $17K | $325K | $277K |
| Stock-Based Compensation | $219K | $274K | $525K | $797K | $559K | $319K | $752K | $31K | $4.22M | $6.57M |
| Change in Receivables | -- | -- | -- | -- | -- | $0 | $690 | $0 | $1.8K | -$12K |
| Change in Inventory | -- | -- | -- | -- | -- | $0 | $1.2K | $0 | $22K | -$454K |
| Change in Payables | -$1.17M | $334K | -$2.26M | $1.31M | -$311K | -$2.8K | -$519K | -$285K | $819K | $309K |
| Operating Cash Flow | -$4.83M | -$4.53M | -$12.85M | -$17.60M | -$10.20M | -$10.31M | -$11.58M | $4.18M | -$27.72M | -$32.05M |
| Capital Expenditure | -$577K | $0 | -- | -- | $0 | -$2.6K | $0 | $0 | -$113K | -$559K |
| Free Cash Flow | -$5.40M | -$4.53M | -- | -- | -$10.20M | -$10.31M | -$11.58M | $4.18M | -$27.84M | -$32.61M |
| Purchases of Investments | -- | -- | -- | -- | -- | -- | -- | -$2.00M | -$32.99M | -$38.68M |
| Investing Cash Flow | $765K | $0 | $0 | -$1.50M | $0 | -$2.6K | $5.61M | $0 | $24.49M | -$12.24M |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | $4.13M | $2.87M | -- | -- |
| Share Repurchases | -- | -- | -- | -- | -- | -- | $0 | -$615K | -- | -- |
| Dividends Paid | -- | -- | -- | -- | -- | $0 | -$134K | $0 | -- | -- |
| Financing Cash Flow | $12.34M | $1.06M | $6.64M | $1.99M | $28.30M | $17.69M | $3.58M | $1.44M | $2.6K | $22K |
| Net Change in Cash | $8.28M | -$3.47M | -$6.21M | -$17.11M | $18.10M | $7.38M | -$2.39M | $5.61M | -$3.23M | -$44.27M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$2.99M | -$2.37M | -$2.22M | -$8.98M | -$873K | -$958K | -$1.71M | -$1.46M |
| Depreciation & Amortization | $25K | $14K | $5.9K | $3.8K | $1.1K | $1.1K | $1.1K | $1.1K |
| Stock-Based Compensation | $253K | $206K | $213K | $140K | $23K | $23K | $34K | $51K |
| Change in Payables | $35K | -$231K | -$4.6K | -$1.19M | -$311K | $83K | $255K | $771K |
| Operating Cash Flow | -$2.59M | -$2.65M | -$2.89M | -$1.14M | -$1.65M | -$862K | -$1.18M | -$743K |
| Financing Cash Flow | $2.55M | $3.16M | $0 | $6.07M | $5.86M | -$141K | $546K | -$107K |
| Net Change in Cash | -$121K | $468K | -$2.89M | $5.90M | $4.01M | -$1.00M | -$636K | -$850K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -- | -- | -- | -- | -- | -- | -- | 77.9% | 60.3% | 34.4% |
| Operating Margin | -- | -- | -- | -- | -696.3% | -148.8% | -238.5% | -86.3% | -2724.6% | -3946.5% |
| Net Profit Margin | -- | -- | -- | -- | -693.8% | -140.5% | -200.2% | -85.6% | -2701.7% | -3907.6% |
| Return on Equity (ROE) | -212.6% | -368.8% | -237.2% | -304.4% | -33.0% | -33.2% | -65.6% | -- | -- | -66.6% |
| Return on Assets (ROA) | -113.2% | -184.4% | -190.4% | -215.7% | -31.3% | -29.5% | -49.9% | -25.2% | -98.4% | -62.5% |
| Current Ratio | 2.13x | 1.98x | -- | -- | -- | -- | -- | 5.76x | 5.91x | 16.06x |
| Quick Ratio | 2.07x | 1.61x | -- | -- | -- | -- | -- | 5.60x | 5.83x | 15.94x |
| Revenue Growth (YoY) | -- | -- | -- | -100.0% | -64.8% | +51.0% | +77.6% | +53.1% | +26.1% | -- |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | +98.0% | +120.7% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -377.2% | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -377.2% | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -364.3% | -334.4% | -336.1% | -212.6% | -- | -- | -9003.4% | -368.8% |
| Return on Assets (ROA) | -188.4% | -160.5% | -154.7% | -113.2% | -82.1% | -366.4% | -238.1% | -184.4% |
| Current Ratio | 1.97x | 1.83x | 1.84x | 2.13x | -- | -- | -- | 1.98x |
| Quick Ratio | 1.92x | 1.77x | 1.72x | 2.07x | -- | -- | -- | 1.61x |